Investor Presentaiton
Consistent capital investments to develop a unique
network of laboratories and state-of-the-art IT solutions
* eurofins
Net Capex (EUR m)
Infrastructure1 Capex (EUR m)
IT 2 Capex (EUR m)
■Machinery and Laboratory Equipment
■Real Estate
361
319
350
2018
2019
2020
270
274
240
2018
2019
2020
64
64
19
64
FY 2020 Key Highlights
Net Capex/Revenues ratio fell to
6.4% of Group's revenues in FY20
vs. 7.0% in FY 2019 as the Group
entered the final stage of its
significant 2015-2020 investment
programme
Net Capex spend of EUR 350m,
with Buildings and Leasehold
improvements representing ca.
40%, Laboratory equipment ca.
35%, and IT Capex ca. 20%
Net Capex spend slightly above the
Group's most recent objective of
EUR 300m, reflecting the
requirements to ramp up the
Group's COVID-19 testing capacity
2018
2019
2020
1 Infrastructure spend includes Land, Building and Leasehold Improvements, Assets in Progress and Machinery and Laboratory Equipment (net of proceeds from sales)
2 IT intangible assets (e.g. software) and hardware capex
72
12View entire presentation